ABSTRACT Receptor-mediated changes in cAMP production play an essential role in sympathetic and parasympathetic regulation of the electrical, mechanical, and metabolic activity of cardiac myocytes. However, responses to receptor activation cannot be easily ascribed to a uniform increase or decrease in cAMP activity throughout the entire cell. In this study, we used a computational approach to test the hypothesis that in cardiac ventricular myocytes the effects of b 1 -adrenergic receptor (b 1 AR) and M 2 muscarinic receptor (M 2 R) activation involve compartmentation of cAMP. A model consisting of two submembrane (caveolar and extracaveolar) microdomains and one bulk cytosolic domain was created using published information on the location of b 1 ARs and M 2 Rs, as well as the location of stimulatory (G s ) and inhibitory (G i ) G-proteins, adenylyl cyclase isoforms inhibited (AC5/6) and stimulated (AC4/7) by G i , and multiple phosphodiesterase isoforms (PDE2, PDE3, and PDE4). Results obtained with the model indicate that: 1), bulk basal cAMP can be high (;1 mM) and only modestly stimulated by b 1 AR activation (;2 mM), but caveolar cAMP varies in a range more appropriate for regulation of protein kinase A (;100 nM to ;2 mM); 2), M 2 R activation strongly reduces the b 1 AR-induced increases in caveolar cAMP, with less effect on bulk cAMP; and 3), during weak b 1 AR stimulation, M 2 R activation not only reduces caveolar cAMP, but also produces a rebound increase in caveolar cAMP following termination of M 2 R activity. We conclude that compartmentation of cAMP can provide a quantitative explanation for several aspects of cardiac signaling.
INTRODUCTION
It is well accepted that receptor-mediated changes in cAMP production play an essential role in autonomic regulation of cardiac function. b 1 -adrenergic receptors (b 1 ARs) increase cAMP production through stimulatory G-protein (G s )-dependent activation of adenylyl cyclase (AC), and M 2 muscarinic receptors (M 2 Rs) antagonize b 1 AR responses through inhibitory G-protein (G i )-dependent inhibition of AC activity. M 2 Rs also produce a delayed stimulatory response that involves an increase in cAMP production (1) .
Despite the large number of studies demonstrating an essential role for cAMP in mediating autonomic responses in the heart, several observations remain incompletely understood. For example, it has been estimated that the cellular concentration of cAMP in cardiac preparations is ;1 mM under unstimulated conditions (2, 3) . Furthermore, cAMP produces most of its acute functional responses through the activation of protein kinase A (PKA). However, the regulatory subunits of PKA bind cAMP with an affinity of 100-300 nM (4, 5) . This suggests that PKA is almost fully activated under resting conditions. If this is true, then how can bAR stimulation of cAMP production elicit responses that are known to involve activation of PKA? One possible explanation, which has been around for over 30 years, is that the changes in cAMP responsible for generating functional responses occur in a microdomain that is somehow isolated from the bulk of the cell (6) . Support for this hypothesis comes from studies demonstrating that changes in the relative amount of cAMP and PKA activity in the membrane or particulate fraction of cardiac preparations correlates more closely with the regulation of functional responses than changes in cAMP activity observed in the soluble or cytosolic fractions (7) (8) (9) .
There are also unanswered questions concerning the mechanisms by which changes in cAMP are involved in muscarinic responses. For instance, it has not always been possible to demonstrate that muscarinic antagonism of b-adrenergic responses corresponds with a decrease in the total cAMP content of cardiac preparations (10) . Furthermore, M 2 R activation can produce cAMP-dependent stimulatory responses in addition to the inhibitory effects. What's more, the stimulatory effects exhibit much slower kinetics (11) (12) (13) . So how can M 2 R activation produce both inhibition and stimulation of cAMP-dependent effects, and why are there differences in the kinetics of the two types of responses? At least part of the answer lies in the fact that cardiac myocytes express multiple isoforms of AC. These include AC5 and AC6 as well as AC4 and AC7 (14, 15 ). Yet, not all AC isoforms respond to G i activation in the same manner. The activated a-subunit of G i (G i a) directly inhibits AC5/6, but not AC4/7 (16) (17) (18) . In fact, AC4/7 is actually stimulated by free bg-subunits released upon activation of G i (19, 20) .
The opposing effects of G i activation on different types of AC activity can explain the inhibitory and stimulatory effects that M 2 R activation has on cAMP-dependent responses in ventricular myocytes (11) . However, it doesn't explain the disparity in the kinetics of the responses. Again, compartmentation of cAMP production may be involved. Evidence in support of this idea comes from studies demonstrating how different components of the signaling pathways are organized in the membrane. For example, AC5/6 is consistently associated with caveolar domains of the plasma membrane, whereas AC4/7 activity is associated with extracaveolar domains (21) . This indicates that muscarinic inhibition and stimulation of cAMP occur in different subcellular locations. This has led us to hypothesize that compartmentation of cAMP can explain the complex temporal response produced by M 2 R activation.
In this study, we used a computational approach to determine whether or not compartmentation of cAMP may be important in answering the above questions. However, earlier models of cAMP signaling in the heart did not consider compartmentation or muscarinic modulation of b-adrenergic responses (22, 23) . Therefore, we developed a new theoretical framework that incorporates existing information on the subcellular location of the various elements involved in cAMP production and degradation as well as the kinetics of critical reactions in both b 1 AR and M 2 R signaling pathways. The resulting model was then used to predict the effects that receptor activation has on cAMP concentrations in caveolar, extracaveolar, and bulk cytoplasmic compartments. The results demonstrate that basal concentrations of cAMP in the caveolar compartment can be maintained at a level significantly lower than that of the total cell so that b 1 AR activation may then regulate the activity of PKA through changes in the concentration of cAMP in this microdomain. The results also demonstrate that even when there are only minimal changes in total cellular cAMP levels, M 2 R stimulation can significantly inhibit cAMP levels in the caveolar domain. Finally, the model demonstrates that the delayed stimulatory response to M 2 R activation is consistent with limited diffusion of cAMP from an extracaveolar domain to the caveolar domain, where PKA activity is regulated.
METHODS

Strategy for model design
Our goal was to determine whether a compartmental model can quantitatively explain the changes in cAMP in cardiac ventricular myocytes in response to activation of adrenergic and muscarinic receptors. We designed the model to be realistic, in the sense of being consistent with available information on the molecules involved. In particular, the model includes multiple isoforms of AC and phosphodiesterase (PDE), which have been proposed to be critical for regulation of cAMP levels. For these reasons, the model includes many molecular entities, each of which requires several parameters to define its functional behavior. Some of the parameters are strongly constrained by existing experimental data, but others are not (as discussed further below). We manually varied the parameters, within the range consistent with existing data, to best describe experimental results on cAMP levels in basal and stimulated conditions. From a mathematical perspective, the model is underdetermined, in that there are more available parameters than are likely to be strictly necessary to produce any single desired output. Consequentially, the parameter set presented here is highly unlikely to be unique. Because our goal was not to provide quantitative estimates for any particular model parameters, we have not performed a formal sensitivity analysis, but we note in the Discussion some of the values that strongly affected key features of the model output. In essence, we present this model as a ''proof of concept'', to demonstrate that a molecularly realistic compartmental model can account for regulation of cAMP levels under a variety of experimental conditions. We expect that this model will also provide a basis for interpreting future studies on molecular perturbations of the system (e.g., inhibition of a particular PDE isoform).
Cell size and composition
A mathematical model of b 1 -adrenergic and M 2 muscarinic receptor regulation of cAMP production in a cardiac ventricular myocyte was developed for this study. As in previous theoretical studies (24) , the myocyte is assumed to be a cylinder with the following characteristics: length ¼ 100 mm, radius ¼ 10 mm, surface area ¼ 6.9 3 10 4 mm
2
, and volume ¼ 38 3 10 À6 ml.
Existing kinetic data on the signaling pathways involved in regulating cAMP production and degradation were incorporated into a model consisting of three different compartments (Fig. 1) . The first is the subsarcolemmal space reflecting the caveolar domains of the cell. The key signaling elements included in that compartment have been found in cholesterol-rich membrane fractions that are associated with caveolin 3, the muscle specific form of FIGURE 1 Compartmentation of cAMP signaling pathways in a cardiac ventricular myocyte. b 1 -adrenergic receptor (b 1 ); M 2 muscarinic receptor (M 2 ); stimulatory (G s ) and inhibitory G-proteins (G i ); adenylyl cyclase type 5 or 6 (AC5/6) and 4 or 7 (AC4/7); phosphodiesterase type 2 (PDE2), 3 (PDE3), and 4 (PDE4); cAMP flux between caveolar and extracaveolar (J Cav/Ecav ), extracaveolar and bulk cytosolic (J Ecav/Cyt ), and caveolar and bulk cytosolic (J Cav/Cyt ) compartments.
caveolin that is involved in creating signaling complexes necessary for producing functional responses (25) (26) (27) . Major signaling components placed in the caveolar domain are b 1 ARs, M 2 Rs, G s , G i , AC5/6, as well as phosphodiesterase types 2 (PDE2), 3 (PDE3), and 4 (PDE4). The size of this compartment is ;1% of the cytosolic volume, and it encompasses 10% of the plasma membrane surface area (28) .
The second compartment reflects the subsarcolemmal space associated with cholesterol-rich lipid rafts that do not include caveolin. In the model, this extracaveolar domain contains b 1 ARs, M 2 Rs, G i , G s , AC4/7, as well as PDE2 and PDE4. The size of this compartment is ;2% of the cytosolic volume, and it encompasses 20% of the plasma membrane. The final domain is the bulk cytoplasmic compartment, which makes up ;50% of the total cell volume (28, 29) and is associated with plasma membrane that contains many of the components described above, but to a lesser degree.
The signaling elements included in the model are listed in Table 1 . They were placed in specific domains based on studies using biochemical methods to detect the presence of protein in different cell or membrane fractions. Due to limited quantitative information, elements that have been reported to exist in more than one domain were assumed to be distributed uniformly between relevant compartments. In some instances, functional studies were used as evidence that a particular signaling element is not uniformly distributed (see below).
Most numerical values used for the parameters found in the model are either taken directly from a single experimental source or constrained by a range defined by multiple experimental sources (see Appendix I). However, no published quantitative data was available for the rate constants for G i activation, the amount of each PDE isoform found in different subcellular compartments, or the cAMP flux rates.
To convert the amount of a specific protein described as a fraction of total membrane protein to the amount of that protein in a single ventricular myocyte, it is assumed that 1 mg of total membrane protein ¼ 7. 
Computational components
Ligand/receptor/G-protein modules The ternary complex model was used to describe the interaction between ligand, receptor, and G-protein (31) . Briefly, the model characterizes the ability of the agonist to promote and stabilize the formation of a high affinity active ternary complex (LRG), starting from a low affinity binary ligandreceptor (LR) complex and G-protein (G). Due to the speed of these reactions (when compared to the other reactions present in the model), they are assumed to be at quasiequilibrium and are represented by algebraic equations. The same formalism was used to describe both b 1 -adrenergic receptor and M 2 muscarinic activation in all relevant compartments.
Module input:
Ligand concentration (constant during a simulation).
Receptor bound G-protein concentration (RG 1 LRG).
G-protein activation module
The ratio between the total number of G i and G s molecules in cardiac cells is ;2:1 (30, 32, 33) . Experimental evidence suggests that there is approximately equal distribution of G s between caveolar and noncaveolar membrane domains, whereas G i is almost entirely present in the caveolar domain (34) . The activation kinetics of G s were derived from published data (35) and modified to obtain subsecond kinetics for G-protein activation, in agreement with previous studies (36) . Although the absolute rate constants for G i activation have not been determined, the rate of G i activation has been reported to be slower than that of G s . Based on this information, it was assumed that the G i activation rate is 50% of that determined for G s .
Module input:
The following formulations are applicable both to G s and G i and their corresponding receptors (b 1 AR and M 2 R).
The output of the combined LRG and G-protein activation modules was validated by comparing the simulated concentration-response curve for isoproterenol stimulation of G s a accumulation (not shown) with published experimental data (37) .
Adenylyl cyclase modules
Adenylyl cyclase activities were divided into two functionally distinct categories: AC5/6 and AC4/7. Both categories are stimulated by G s activation, but with very different affinities. The EC 50 for G s a stimulation of AC4/7 is ;32 nM, whereas for AC5/6 it is ;200 nM (38, 39) . This significantly affects the sensitivity of each AC category to b 1 AR stimulation. Each category of AC activity is also affected differently by G i activation. AC5/6 is inhibited by G i a, whereas AC4/7 is not. Furthermore, AC4/7 is stimulated synergistically by G i bg in the presence of G s a activation (39) . As described below, parameter values were obtained by using a Hill equation to fit the experimentally determined relationship between G-protein subunits and AC activity. Adenylyl cyclase 5/6 module. The activity of AC5/6 and its regulation by G s and G i were simulated using a formulation to describe data obtained from isolated membrane preparations (37, 40) . This activity was then scaled up using an amplification factor (AF 5/6 ) that was defined by the ratio of the activity produced by equal amounts (1 mg) of purified and membrane protein in the presence of a maximally stimulating concentration of G s a.
Module input:
Gs a and Gi a concentration (Gs a-GTP , Gi a-GTP 
Adenylyl cyclase 4/7 module. AC4/7 activity and its regulation by G s and G i were simulated using a formulation based on published experimental data (41, 39, 42) . Because of their structural and functional similarities (43) , the kinetic properties of AC2 were used to describe the behavior of AC4/7, where necessary. The total amount of AC4/7 present in the cell was assumed to be ;10% of AC5/6 (44, 45 ). An amplification factor (AF 4/7 ) was calculated as it was for AC5/6.
Gs a and Gi a concentration (Gs a-GTP , Gi bg ). 
Phosphodiesterase modules
The total cellular protein content of the various PDE isoforms found in cardiac myocytes has been reported. However, the only information available on the subcellular location of the different PDE isoforms describes their presence in membrane (particulate) and/or cytosolic (soluble) fractions. How the membrane associated PDE activity is distributed between caveolar and extracaveolar domains is not known. The available descriptive information, along with functional studies, was used as a guide in determining the relative ratio of each PDE isoform to be included in the various compartments.
Module input: cAMP concentration for the specific compartment. Module output:
cAMP degraded by PDEs.
The general formulation used for each PDE isoform (PDEx) is:
cAMP flux modules
Initial rates for flux of cAMP between compartments were based on previously published estimates (46) .
Implementation and validation
The model was implemented in Java (J2SE 
RESULTS
Basal cAMP levels
We first validated the model's prediction of cAMP levels under basal conditions. In the absence of any agonist, previous studies have suggested that the basal concentration of cAMP in cardiac myocytes is ;1 mM (2,3). However, this is well above the cAMP affinity of PKA (#300 nM), which is the primary effector for this cyclic nucleotide (4, 5) . This apparent discrepancy may be due to cAMP measurements having been made using traditional biochemical methods involving homogenized tissue or whole cell lysates, which represent what is happening on average throughout the whole cell, but may not accurately reflect what is happening in discrete microdomains where PKA-mediated functional responses are regulated. Consistent with this idea, the model demonstrates that under basal conditions, it is possible to maintain the average concentration of cAMP across all compartments (total cAMP) at 1 mM, while in the caveolar domain, the basal concentration is ;100 nM (see Fig. 2 ). Although this level of cAMP is high enough to partially activate PKA, it is still low enough to leave a concentration range over which cAMP can significantly modulate kinase activity.
Effects of b-adrenergic receptor stimulation
We next evaluated the effect that b 1 AR stimulation has on cAMP levels. As expected, the model predicts that b 1 AR stimulation causes a concentration-dependent increase in cAMP in all compartments of the cell (Fig. 2) . Exposure to the b 1 AR agonist isoproterenol (Iso) increases total cAMP from basal (1 mM) to a maximal level ;2.1 mM with an EC 50 of ;7 nM. This is consistent with the 50-250% increase over baseline, and EC 50 of 10-80 nM observed experimentally, when using traditional biochemical methods to measure total cAMP in homogenized preparations (7, 9, (48) (49) (50) (51) . The model also predicts that caveolar cAMP reaches a similar concentration following maximal b 1 AR stimulation, but because of the lower baseline (100 nM), the overall change represents a .2000% increase. Recently, we have used a fluorescence energy transfer (FRET)-based biosensor to measure changes in cAMP activity in intact cardiac myocytes (47) . This biosensor consists of fluorescently labeled type II PKA, and in adult ventricular myocytes it is expressed in a striated pattern, suggesting that it is associated with T tubules, just like endogenous type II PKA (52, 53) . Caveolin-3, a marker for caveolae, is expressed in a similar striated pattern, in addition to being found in the peripheral sarcolemma (54) . Biochemical studies have also demonstrated that type II PKA is highly enriched in caveolar membrane fractions (34) . Therefore, it is assumed that this sensor responds to changes in cAMP activity occurring in a caveolar compartment. Consistent with this idea, we have previously demonstrated that this sensor detects b 1 AR stimulated changes in cAMP activity with a sensitivity that correlates directly with the b 1 AR sensitivity of L-type Ca 21 channels (47), which are located in caveolae associated with T tubules (55) . The properties of this probe have also been well characterized in vitro (4). The EC 50 for cAMP activation is 300 nM, with a Hill coefficient of 1.4. Furthermore, activation by maximally effective concentrations of cAMP produces a FRET response of ;15% (see Fig. 3 B) . However, when expressed in ventricular myocytes, this probe exhibits a smaller dynamic FRET response (6-12%) following maximal agonist stimulation (47, 4) . This can be explained if basal levels of cAMP are sufficient to have partially activated PKA, even before exposure to agonist. Consistent with this idea, PKA-dependent responses can be elicited from ventricular preparations by inhibiting basal phosphatase activity (56) .
If the in vitro properties of the probe described above hold true in vivo, and if we assume that the average maximal FRET response that can be elicited in adult ventricular myocytes is 9%, this then indicates that ;25% of the PKA-based probe must be in an active state under basal conditions. This corresponds to a basal level of cAMP that is close to that predicted by the model to exist in the caveolar domain. Using the relationship between Iso concentration and cAMP levels in the caveolar compartment (Fig. 2 C) , we then defined the expected relationship between Iso concentration and PKA activation. According to this calculation, Iso increases PKA activity from a basal level of 25% to maximal with an EC 50 of 1.3 nM (Fig. 3 D) . The sensitivity of this response is in good agreement with the EC 50 of 0.5 nM for Iso activation of the PKA-based probe in intact ventricular myocytes (47) . With the relationship in Fig. 3 B, we can also use the model to predict the FRET response of the PKA-based probe (Fig. 3 C) and compare this to experimentally determined PKA-FRET responses (Fig. 3 A) . The model's predictions are in good agreement with the experimental results. The one possible exception is the difference in the time course with which responses turn on and off. Although there may be more than one explanation, it is most likely due to the slow exchange of solutions used to add or remove drugs during the imaging experiments (47) . Consistent with this conclusion, the time course of the responses predicted by the model are more in line with the time course of cAMP-dependent ion channel responses observed when rapid solution changes are possible (13) .
Effects of M 2 R activation in the presence of maximal b-adrenergic stimulation M 2 R activation is able to antagonize responses to agonists that stimulate cAMP production. Although it is now generally accepted that such inhibitory effects are due to a decrease in cAMP production, this has not always been the case (1). Many early studies measuring cAMP levels in homogenized tissue or whole cell lysates found that muscarinic inhibitory responses do not correlate with changes in cAMP. An explanation offered for this apparent paradox has been that muscarinic inhibition of cAMP activity is localized to specific subcellular compartments (10) . Consistent with this idea, the model predicts that M 2 R stimulation has only modest effects on total cAMP levels (Fig. 4 C) . However, M 2 R activation significantly reduces cAMP in the caveolar compartment (Fig. 4 D) . Furthermore, ACh inhibition of the Iso response is reflected in the predicted FRET response (Fig. 4 B) , which correlates well with the PKA FRET response observed experimentally (Fig. 4 A) . Another prediction of the model is that following the initial inhibitory effect produced by ACh, there is a gradual decrease in inhibition (''escape''), as observed experimentally (13) . In the model, this is due to M 2 Rs stimulating cAMP production in the extracaveolar compartment, which then spills over into the caveolar compartment.
Effects of M 2 R activation in the presence of submaximal b-adrenergic stimulation
Having demonstrated that the model can reproduce muscarinic inhibition of b 1 AR-mediated cAMP production, we then evaluated its ability to explain muscarinic stimulatory responses. Previous studies in ventricular myocytes have demonstrated that muscarinic stimulatory effects are only observed in the presence of submaximal concentrations of agonists such as Iso (11) (12) (13) . Consistent with this, the model predicts that M 2 R activation would not produce a detectible rebound stimulatory response in the presence of a maximally stimulating concentration of Iso (Fig. 4 B) . However, in the presence of a concentration of Iso that is near the threshold for stimulating PKA activity above basal levels, the model predicts that upon termination of M 2 R activation, there should be a significant rebound stimulatory increase in cAMP concentration in the caveolar compartment, which produces a rebound increase in the predicted PKA FRET response (Fig. 5 B) . This type of response correlates with the PKA-FRET response observed experimentally (Fig. 5 A) . Again, the slower time course of the FRET response measured experimentally may be explained by the time required to change solutions. The model also predicts an inhibitory effect that goes below baseline during exposure to ACh, but the PKA-based probe may not be able to detect changes in cAMP below basal levels (see Appendix II).
A more detailed examination of the source of cAMP responsible for the rebound stimulatory response helps explain this complex behavior. This requires an appreciation of what is happening not only in the caveolar compartment, but also in adjacent compartments, especially the extracaveolar compartment. In the model, M 2 Rs are located in both the caveolar and extracaveolar compartments. However, the caveolar compartment contains only AC5/6 activity, while the extracaveolar compartment contains only AC4/7 activity. In the presence of ACh, G i a inhibits AC5/6, rapidly reducing cAMP in the caveolar compartment (Fig. 6, A and B) . However, ACh actually increases cAMP in the extracaveolar compartment, where G i bg stimulates AC4/7 (Fig. 6 D) . The resulting concentration gradient produces a slow flux of cAMP between compartments (Fig. 6 C) , but the inhibitory effect of ACh on cAMP production within the caveolar compartment dominates. Upon washout of ACh, AC5/6 inhibition quickly reverses, resulting in a rapid return of cAMP production within the caveolar compartment. This cAMP, together with flux of cAMP from the extracaveolar compartment, results in a caveolar concentration exceeding that observed in the presence of Iso alone (before application of ACh). As the concentration of cAMP in the extracaveolar compartment declines, so does the flux of cAMP into the caveolar compartment. The result is that caveolar cAMP declines to its steady-state value. Based on these results, we conclude that the diffusion of cAMP from the extracaveolar compartment into the caveolar compartment is a viable explanation for the rebound stimulatory responses observed upon washout of ACh.
DISCUSSION
Computational models of cAMP signaling have recently been used to investigate cardiac myocyte responses to b 1 AR stimulation (23, 22) . This study expands this approach by incorporating the kinetics of processes involved in b 1 -adrenergic as well as M 2 muscarinic regulation of cAMP production and integrating this with information on the subcellular distribution of the various components of these signaling pathways. The model was tested by comparing cAMP responses predicted to occur in a caveolar compartment to previously published measurements of changes in cAMP activity detected by a FRET-based biosensor targeted to the corresponding subcellular location of intact cardiac ventricular myocytes (47) . It was also tested by comparing total cAMP responses (using the weighted average of the cAMP concentrations in all three compartments) to previously published measurements of changes in cAMP obtained using traditional biochemical methods in ventricular tissue homogenates and/or whole cell lysates. This new theoretical framework can explain both simple and complex behaviors of cardiac ventricular myocytes evoked by both b 1 -adrenergic and M 2 muscarinic signaling pathways.
The model provides a simple explanation for the observation that the total cellular cAMP level is high enough that one would expect near maximal activation of PKA, even under basal conditions. Measurements obtained using homogenized cells or tissue reflect cAMP levels averaged across the whole cell, not levels in microdomains that make up only a small fraction of the total cell volume. Although compartmentation of cAMP signaling is an obvious potential explanation, that hypothesis is difficult to evaluate experimentally. The model predicts that bulk cytoplasmic cAMP is comparable to previous estimates for the whole cell, but cAMP in the caveolar compartment operates in a range appropriate to modulate PKA activity. This obviates the need to assume that the affinity of PKA for cAMP is significantly lower in vivo than what has been measured in vitro (22, 57) .
The model also can explain why muscarinic inhibition of b-adrenergic functional responses has not always been found to correlate directly with changes in cAMP levels (10) . Because the discrepancies have been reported in studies where cAMP levels were measured using whole cell or tissue preparations, it has been proposed that significant concentration changes actually were occurring in microdomains where PKA-dependent responses are regulated (10) . In support of this idea, the model predicts that M 2 R activation causes only modest changes in cAMP concentration in the bulk cytoplasmic compartment (see Fig. 4 C) , whereas there are significant changes in cAMP levels in the caveolar compartment (see Fig. 4 D) . Furthermore, the predicted effect of M 2 R activation on PKA responses in the caveolar compartment (Fig.  4 B) correlates well with experimental results demonstrating that, in the presence of b 1 AR stimulation, M 2 R activation reduces cAMP activity detected by the PKA-based cAMP biosensor (Fig. 4 A) .
We then used the model to determine whether compartmentation of cAMP can explain M 2 R-mediated delayed stimulatory responses. In ventricular myocytes, this behavior is due to G i bg subunits stimulating AC4/7 activity (11). However, this occurs at the same time that G i a is inhibiting AC5/6. So why does the stimulatory effect produce a rebound response upon termination of M 2 R activation? If AC4/7 and AC5/6 are found in different plasma membrane domains (21), we hypothesized that a time-dependent flux of cAMP from an extracaveolar compartment to a caveolar compartment could be responsible. The model demonstrates that this is a feasible explanation. It is interesting to note that the muscarinic stimulatory mechanism only affects functional responses (e.g., ion channels) in the presence of submaximally stimulating concentrations of Iso. The model actually predicts that the muscarinic stimulatory response affects cAMP levels even in the presence of maximally stimulating concentrations of Iso, but because this rebound response is above the level that maximally activates PKA, it is not expected to produce a detectable functional response (see Fig. 4 ).
Limitations and predictions
Although descriptive information dealing with compartmentation of cAMP signaling in cardiac myocytes is growing rapidly, the availability of quantitative data is limited. Where information does exist, it is not uncommon for there to be some variability in estimates between different studies. Because of this, there may be more than one set of parameters that produce the same behaviors we have described. In this respect, this version of the model should be viewed as just one potential configuration, albeit one that exhibits properties consistent with a number of experimental observations. Although a quantitative parameter analysis was beyond the scope of this study, we did conduct a more qualitative type of analysis of the importance of certain parameter in producing specific responses.
Except where noted, the equations used in the model's different modules were taken from previously published studies. This approach constrained many parameter values to those that resulted in module output consistent with experimental data. Less quantitative information was available for assigning values to other parameters. This is particularly true for the distribution of some signaling elements among subcellular compartments and the flux rates for cAMP between compartments. These were the parameters that turned out to have the greatest influence on the behaviors that were the focus of this study.
Experimental data also do not provide a consistent view on the location of b 1 ARs. Some studies have suggested that the bulk of the b 1 AR population exists in an extracaveolar domain (34) , whereas others have concluded that the same receptor is found predominantly in a caveolar domain (58) . The present version of the model assumes that b 1 ARs are found in both of these compartments. The validity of this assumption might be questioned, but it was necessary in order for b 1 AR stimulation to activate both AC5/6 and AC4/7. Stimulation of AC5/6 was necessary to produce an increase in cAMP that could then be inhibited by M 2 R activation. Stimulation of AC4/7 was necessary to see AChinduced rebound stimulation of cAMP production. Because these different AC isoforms are found in different membrane domains (21, 27) , the simplest way to model these behaviors was to include b 1 ARs in those domains as well. This illustrates how the model can be used to evaluate the functional significance of biochemical data describing the location of specific elements or even differentiating between possibilities. Using this approach, our results provide support for the idea that b 1 ARs actually exist in caveolar as well as extracaveolar domains.
One aspect of the model that is absolutely critical for producing the ACh-induced rebound stimulatory response is the placement of AC5/6 inside and AC4/7 outside of the caveolar compartment. Although this behavior is not lost if the distribution of AC isoforms is less strict, segregation of the majority of AC activity is important. This conclusion is consistent with biochemical studies that have looked at the distribution of AC activity in different membrane fractions (27, 21) .
It was not necessary to include more than one type of PDE activity to obtain the basic properties of this model. What was important was the ratio of PDE to AC activity in each compartment. Furthermore, it was critical to have much higher total PDE activity in the caveolar compartment than either of the other two compartments. This was necessary to maintain a low concentration of cAMP in the caveolar domain under basal conditions, while still allowing cAMP levels in the other compartments (and thus total cAMP) to remain high. Similarly, the transient rebound response observed following washout of ACh can be reproduced by including a single type of PDE activity in the extracaveolar domain that is much lower than that in the caveolar compartment. So one might question why we included three different types of PDE activity in the model. The primary reason is that there have been numerous studies demonstrating the functional importance of PDE2, PDE3, and PDE4 activity in regulating cAMP-dependent responses in adult cardiac myocytes (59, 60) , and we wanted the model to reflect what is known about PDE activity in these cells. Unfortunately, there is little information available on how the different PDE isoforms are distributed. Biochemical studies have found evidence for all three isoforms in both soluble and particulate fractions of cell homogenates, and while the PDE activity in particulate fractions may be membrane associated, there is little or no information on how much of that might be caveolar and/or extracaveolar. Fortunately, the behaviors described by this model did not depend critically on exactly which PDE isoforms were present in each compartment. Another reason to include multiple PDE isoforms in the model is that each can be regulated in unique ways that may be necessary to explain other types of responses. For example, PDE4 can be activated by PKA (61) . Previous work has suggested that this is involved in a feedback mechanism that can modulate the magnitude of cAMP responses detected by exogenously expressed cyclic nucleotide gated (CNG) ion channels (62) . However, the subcellular location where this positive feedback activation of PDE4 may be occurring is not clear. Although it is obvious that CNG channels detect responses near the plasma membrane, they are expressed primarily in noncaveolar lipid rafts (63) , and how this may relate to compartments included in this model is not known.
The parameters about which we have the least information relate to the flux of cAMP within a cell. Movement of cAMP between compartments is often thought of as being limited by functional barriers associated with PDE activity (7) . In this model, the role of PDE activity in regulating the flux between compartments is actually through its contribution to the concentration of cAMP in each compartment, and therefore the concentration gradient driving cAMP movement between compartments. Flux of cAMP between compartments is also a function of physical factors affecting diffusion of cAMP down its concentration gradient. If it is assumed that there are no physical barriers and cAMP can move between compartments at rates that approximate free diffusion, all of the behaviors attributed to compartmentation by this model are lost. This includes the gradient of cAMP between the caveolar and extracaveolar domain under basal conditions, as well as the ACh-induced rebound stimulatory response. The complex structure of cardiac ventricular myocytes has been shown to restrict access to submembrane regions and is likely to be an important factor influencing cAMP diffusion (64) , but the actual nature of the barriers between compartments proposed in the model is not known. The flux rates predicted by this model indicate that cAMP movement is far slower than free diffusion. Validation of these values awaits development of an approach to experimentally determine cAMP flux rates between specific microdomains in intact myocytes. It is noteworthy that Rich et al. 
CONCLUSIONS
This work supports the idea that compartmentation of cAMP signaling plays a critical role in shaping cAMP-dependent effects under basal conditions, as well as in response to b 1 AR and M 2 R activation. This includes both the inhibitory and stimulatory responses associated with M 2 R activation.
APPENDIX I
All parameters used in the model and their respective references are listed in Tables 2-8 . (56) . Consistent with this idea, the model actually predicts that exposure to ACh alone does cause a decrease in caveolar cAMP levels ( Fig. 7 D) , as well as a decrease in the predicted FRET-response (Fig. 7 B) . However, ACh has no effect on the FRET-response of the PKA-based biosensor in intact cardiac ventricular myocytes (Fig. 7 A) . This apparent discrepancy is most likely due to the inability of the sensor to detect decreases in basal cAMP activity.
In cells expressing the PKA-based biosensor, acute exposure to an agonist that stimulates cAMP production causes a decrease in FRET (increase in the FRET response) that is readily reversible (Figs. 3-5 ). This can be explained by the fact that cAMP binding to RII-CFP does not necessarily cause complete dissociation of Cat-YFP in the absence of substrate (47) . Therefore, these labeled subunits can readily reassociate when cAMP levels 
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Flux rate between Ecav and Cyt compartments (65) decrease, resulting in an increase in FRET (decrease in FRET response). However, under basal conditions, it is more likely that the regulatory and catalytic subunits of activated PKA do completely dissociate. In this situation, there is a greater chance that fluorescently labeled subunits reassociate with unlabeled endogenous counterparts, in which case there will be no change in FRET, or the FRET response. Therefore, the absence of a decrease in the FRET response upon exposure to ACh under basal conditions does not necessarily mean that cAMP levels have not decreased. The model also predicts that exposure to high concentrations of ACh actually causes a slight increase in total cAMP (Fig. 7 C) . Although this type of response might seem counterintuitive, it is consistent with what has been observed experimentally when measuring cAMP responses with biochemical methods in ventricular tissue homogenates (68) . The model can explain such effects as being due to the ability of M 2 R activation to stimulate cAMP production in the extracaveolar compartment.
